On Thursday, August 9, Cumberland Pharmaceuticals Inc. filed suit against Perrigo Co. for seeking approval to market an Acetadote® copy prior to the expiration of the original drug’s underlying patent issued in April of this year, U.S. Patent Number 8,148,356. Cumberland is represented by Finnegan in this matter.
Press Release
September 11, 2024
Announcement
September 3, 2024
Award/Ranking
Savoy Magazine Names Mareesa Frederick on its 2024 Most Influential Lawyers List
August 2, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.